BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Drupal//recurring_events_ical//2.0//EN X-WR-CALNAME:2026 Santa Barbara Dermatology Meeting BEGIN:VEVENT UID:21d2fb87-b395-43df-a933-f629a695a430@events.dev.louisville.edu DTSTAMP:20260610T114532Z DTSTART:20261203T190000Z DTEND:20261204T050000Z SUMMARY:2026 Santa Barbara Dermatology Meeting CONTACT:Gregory Cameron\, 615-579-8798\, email:sbderm@sanluisdermatology.co m DESCRIPTION:Each year, nationally recognized leaders in medical, procedural , and aesthetic medicine convene in Santa Barbara to discuss and review th e current state of knowledge in their respective dermatologic specialties. This program in medical dermatology features key clinical topics, includi ng atopic dermatitis, acne vulgaris, cutaneous cancers, rosacea, psoriasis , and other important issues. Aesthetic medicine continues to be a growing specialty in the milieu of the aging American population and medical cons umers’ ever-increasing desire to achieve the best possible quality of li fe at any age.\n\n\n Agenda\n Brochure\n CE Credit\n Course Directors & Fa culty\n Registration\n\n\n\nTarget Audience\nDermatologists, Nurse Practit ioners, Physician Assistants, and Registered Nurses.\n\nAgenda\n\nTHURSDAY December 3, 2026\n2:00 p.m. -5:00 p.m.    \nRegistration and Check-In\ n\nFRIDAY December 4, 2026\n\n7:00-4:00 p.m.    \nRegistration Open\n\n 7:00-8:30 a.m.   \nBreakfast\n\n8:30-9:00 a.m.    \nLecture: Update o n Alopecia & the New Treatments\nNeal Bhatia, MD\n\n9:00-9:30 a.m.     \nLecture: Lessons Learned From Audits\nBrent Moody, MD\n\n9:30-10:00 a.m.     \nLecture: Exciting Updates and Challenges in Psoriasis Care \nApr il Armstrong, MD\n\n10:00-10:20 a.m.\nBreak\n\n10:20-10:50 a.m.\nLecture: Therapeutic Advances in Pediatric Dermatology\nAnthony Mancini, MD\n\n10:5 0-11:20 a.m.\nPanel Q&A\nMorning Panel: Neal Bhatia, MD; Brent Moody, MD; April Armstrong, MD; Anthony Mancini, MD \n\n11:20-11:50 a.m.\nLecture: Double Duty: Selecting or Avoiding Psoriasis Therapy by Dual Indication \ nKristina Callas Duffin, MD\n\n11:50-1:30 p.m.\nLunch/Break/Exhibits        \n\n1:30-2:00 p.m.\nLecture: Update on Chronic Urticaria\nTed Lain, MD\n       \n2:00-2:30 p.m.\nLecture: TBD\nTBD\n\n2:30-3:00 p.m.\nL ecture: Navigating Cosmeceuticals\nKavita Mariwalla, MD\n\n3:00-4:00 p.m. \nLecture: Great Cases in Dermatopathology\nBruce Ragsdale, MD\n\nSATURDA Y December 5, 2026 \n\n \n\n7:00-4:00 p.m.   \nRegistration Open\n\n7: 00-8:30 a.m.    \nBreakfast     \n\n8:30-9:00 a.m.\nLecture: Billing & Coding\nBrent Moody, MD\n\n9:00-9:30 a.m.\nLecture: The Child with a Re d Rash\nAnthony Mancini, MD\n\n9:30-10:00 a.m.\nLecture: Atopic Dermatolog y: Systemics Update \nEric Simpson, MD\n\n10:00 10:20 a.m.\nBreak\n\n10:2 0-10:50 a.m.\nKeynote Lecture: Stopping the Spiral in Hidradenitis\nApril Armstrong, MD\n\n10:50-11:10 a.m.\nPanel Q&A    \nMorning Panel: Brent Moody, MD; Anthony Mancini, MD; Eric Simpson, MD; April Armstrong, MD \n \n11:10-12:00 p.m.\nLecture: Surgical Dermatology Pearls\nRoberta Sengelma nn, MD: Kavita Mariwalla, MD; Brent Moody, MD \n\n12:00-1:30 p.m.\nLunch/ Break/Exhibits    \n    \n1:30-2:30 p.m.\nTherapeutics Master Panel\ nApril Armstrong, MD; Ted Lain, MD; Anthony Mancini, MD; Michael Heffernan , MD\n\n2:30-4:30 p.m.\nLIVE Patient Demonstration\nRoberta Sengelmann, MD ; Kavita Mariwalla, MD \n\nSUNDAY December 6, 2026   \n\n7:00-12:00 p.m .    \nReception Desk Open\n\n7:00-8:30 a.m.    \nBreakfast \n\n\n8 :30-9:00 a.m.\nLecture: Controversies in Surgical Dermatology\nRoberta Se ngelmann, MD\n\n9:00-9:30 a.m.\nLecture: Skin: The Frontline Longevity Org an\nTed Lain, MD\n\n9:30-10:00 a.m.\nLecture: When Bad Things Happen to Go od Dermatologists: Learning From Complications Conference\nEric Simpson, M D\n\n10:00-10:30 a.m.\nLecture: Dermatology Therapeutic Pipeline\nNeal Bha tia, MD\n\n10:30-11:00 a.m.\nMorning Q&A \nMorning Panel: Ted Lain, MD; E ric Simpson, MD; Neal Bhatia, MD\n\n11:00-12:00 p.m.\nLecture: Grand Round s \nNeal Bhatia, MD; Eric Simpson, MD; Michael Heffernan, MD \n\n12:00 p .m.\nAdjourn/Box Lunch\n\nCourse Directors\n\n \n\nApril Armstrong, MD FA AD   \n\nDr. April Armstrong is Professor and Chief of Dermatology at Un iversity of California Los Angeles (UCLA). She is an internationally renow ned dermatologist and clinical researcher in inflammatory skin diseases in cluding psoriasis, atopic dermatitis, and HS.\n\nDr. Armstrong obtained he r medical degree from Harvard Medical School and completed dermatology res idency at Harvard. She also obtained a Master of Public Health degree from Harvard School of Public Health. Prior to being the Chief of Dermatology at UCLA, Dr. Armstrong served as Associate Dean for Clinical Research at t he University of Southern California (USC), where she led initiatives to i mprove research infrastructure and streamline processes to provide an effi cient environment for research. She also served as Vice Chair in the Depar tment of Dermatology at USC, as well as at the University of California Da vis and University of Colorado previously.\n\nDr. Armstrong is a federally funded investigator whose research focuses on (1) evaluating novel system ic and topical therapies for inflammatory skin diseases, (2) identifying t reatment goals and comorbidities associated with skin diseases, and (3) in creasing patient access using innovative, technology-enabled healthcare de livery methods. Dr. Armstrong has conducted over 150 clinical trials and p ublished over 500 articles in scientific journals.\n\nDr. Armstrong has a long history of service to the medical profession on a national and intern ational level. She serves as a board member of the American Academy of Der matology, immediate Past Chair of the Medical Board at the National Psoria sis Foundation, Co-President of the Group for Research and Assessment of P soriasis and Psoriatic Arthritis (GRAPPA), councilor for the International Eczema Council and International Psoriasis Council, and a board member fo r the International Dermatology Outcome Measures and the California Societ y of Dermatology and Dermatological Surgery (CalDerm). She is also an edit orial board member of JAMA Dermatology and had also served on the editoria l boards of JAAD and other journals. Dr. Armstrong is past President of th e American DermatoEpidemiology Network and Sacramento Valley Dermatology S ociety.\n\nDr. Armstrong is also a passionate educator, having mentored nu merous medical students, residents, and postdoctoral research fellows. She has received institutional and national teaching awards for her education al efforts.\n\nNeal Bhatia, MD \n\nDr. Neal Bhatia is a board-certified d ermatologist in San Diego, California.  He serves as Director of Clinical Dermatology at Therapeutics Clinical Research and as chief medical editor for Practical Dermatology.  He is widely published and has a background in immunology as well as interests in mechanisms of therapy, skin cancer, and medical dermatology\n\nMichael Heffernan, MD \n\nDr. Heffernan is an internationally recognized complex medical dermatologist and clinical tria list. After serving as the  founding chair of Dermatology at the Wright S tate University Boonshoft School of Medicine he served as a Distinguished  Medical Fellow for Eli Lilly & Co. He is now the co-owner of San Luis De rmatology & Laser Clinic and he is the US  Dermatology Lead for Probity M edical Research. Dr. Heffernan has published over 80 peer reviewed article s and  textbook chapters. He has been the principle investigator for near ly 150 research studies and he has provided over 500  invited lectures ar ound the globe \n\n \n\nLearning Objectives\nAs a result of participatin g in this activity, the participants will be able to:\n1. Discuss new appr oaches to therapy including pathway targeted therapy in the treatment of m elanoma.\n2. Assess the role of diagnostic tools and technology in diagnos is and detection of skin cancers.\n3. Compare and contrast the efficacy an d safety of agents, devices, and techniques currently available in aesthet ic and procedural dermatology.\n4. Integrate into daily practice evidence- based recommendations on new and emerging therapies for common dermatologi c diseases.\n5. Analyze treatment approaches for the pediatric patient wit h common as well as complex skin diseases.\n6. Implement updated strategie s for managing acne, rosacea, atopic dermatitis, contact dermatitis and ps oriasis.\n7. Recognize the factors that are important in selecting appropr iate filler agents for treating different areas of the face and targeted p lanar depths.\n8. Determine the appropriate nonsurgical techniques for fac ial rejuvenation based on an enhanced understanding of facial anatomy.\n9. Explain the roles of currently available biologic agents in the treatment of psoriasis and psoriatic arthritis, and appropriately incorporate newer biologics into therapeutic practice as these become available.\n10. Incor porate the recent research advances in understanding and treating pediatri c dermatology issues such as atopic dermatitis and pediatric acne.\n\nCont inuing Education Credit\nJoint Provider Accreditation Statement\n\nThis ac tivity has been planned and implemented in accordance with the accreditati on requirements and policies of the Accreditation Council for Continuing M edical Education (ACCME) through the joint providership of the University of Louisville School of Medicine and the Foundation for Dermatology Educat ion. The University of Louisville is accredited by the ACCME to provide co ntinuing medical education for physicians.\n\nPhysician Credit\n\nThe Univ ersity of Louisville Continuing Medical Education office designates this l ive activity for a maximum of 15.25 AMA PRA Category 1 Credits™. Physi cians should claim only the credit commensurate with the extent of their p articipation in the activity.\n\n\nPlease note: California PAs, Californi a RNs and California NPs can all earn AMA PRA Category 1 Credit(s)™.\n\ nNursing Credit\nThis program has been approved by the Kentucky Board of N ursing for 18.3 continuing education credits through University of Louisvi lle Hospital, provider number 4-0068-12-26-1483. The Kentucky Board of Nur sing approval of an individual nursing education provider does not constit ute endorsement of program content. Completion criteria to obtain CE's: At tend entire session and complete the evaluation.\n\n\nSpecial Services\nAl l individuals are encouraged to participate. To request disability arrange ments, please contact Gregory Cameron at least 14 days prior to the date of this program. Continuing Medical Education and Professional Developmen t fully complies with the legal requirements of the ADA and the rules and regulations thereof.\n\n\n\nRegistration\nRegistration Options and Fees:\n 1. Residents/Fellows  $150\n2. All Others - $750\n3. Industry Representat ive  $2,000\n\nRegister Here\n\nRefund Policy\nRequests for cancellation must be submitted to chse@louisville.edu on or before Friday, November 2 0, 2026. Requests received on or before Friday, November 21, 2025 will r eceive a full refund less a $50 processing fee. No refund will be given fo r requests received after Friday, November 20, 2026.\n\nLodging/Reservatio ns\nDetails for Lodging/Reservations will be forwarded upon completion of registration.\n\nGeneral Venue Information (Not For Reservations)\nCLICK H ERE to go to the Ojai Valley Inn Website\n\n\nAccreditation Disclosure\nA s a provider accredited by the ACCME, the Office of CME&PD, School of Medi cine, University of Louisville, must ensure balance, independence, objecti vity, and scientific rigor in all its accredited educational activities. A ll Planners, faculty, reviewers, and other persons that affected the conte nt of this CME activity were required to submit a financial disclosure for m from which relevant conflicts of interest were determined. If any releva nt financial relationship(s) with ineligible companies were disclosed, the materials each of them prepared for this program (or influenced) were pee r-reviewed and determined to be without ineligible company bias, were cons idered fair and balanced in terms of therapeutic options, and presented ev idence-based content. All relevant financial relationships with ineligible organizations have been mitigated prior to this activity.\n\nLearner Cons ent Statement\nNames or contact information of learners will not be shared with any ineligible company or its agents without the explicit consent of the individual learner.\n\nAcknowledgments\nWe thank our supporting and e xhibiting companies for their participation in the conference! A final li sting of supporters and exhibitors will be available at the meeting. URL:https://events.dev.louisville.edu/events/2026-santa-barbara-dermatology -meeting/2026-12-03 END:VEVENT END:VCALENDAR